Skip to main content
Skip to main menu
Skip to footer
A
A
A
English
Español
Advanced Search
Claims & Payments
Claim Appeal
Electronic Data Interchange
Provider Payment Method
Refunds & Recoupments
Reimbursement Policies
Prior Authorization
BH Clinical Guidelines & Medical Policies
PH Clinical Guidelines & Medical Policies
Prior Auth Lookup Tool
Prior Authorization Appeal & Resubmission
Prior Authorizations - Pharmacy
Prior Authorizations - Vision
Our Network
Clinical Practice Guidelines
Cultural Competency
Join Our Network
Provider Credentialing
Provider Directory
Manual & Training
Quality Improvement
Resources
Appeals & Complaints
Contact Us
Electronic Visit Verification
Forms & Resources
HIPAA
Member Handbooks & Rights
Provider Events
Provider Tool Kit
State Programs
Communications
Provider Network News
Provider Newsletters
TMHP & HHSC Notices
Members
Claims & Payments
Claim Appeal
Electronic Data Interchange
Provider Payment Method
Refunds & Recoupments
Reimbursement Policies
Prior Authorization
BH Clinical Guidelines & Medical Policies
PH Clinical Guidelines & Medical Policies
Prior Auth Lookup Tool
Prior Authorization Appeal & Resubmission
Prior Authorizations - Pharmacy
Prior Authorizations - Vision
Our Network
Clinical Practice Guidelines
Cultural Competency
Join Our Network
Manual & Training
Provider Credentialing
Provider Directory
Quality Improvement
Our Services
Behavioral Health
Care Management
Dental
NEMT
Pharmacy
Vision
Resources
Appeals & Complaints
Contact Us
Electronic Visit Verification
Forms & Resources
HIPAA
Member Handbooks & Rights
Provider Events
Provider Tool Kit
State Programs
Communications
Provider Network News
Provider Newsletters
TMHP & HHSC Notices
Find a Provider
Portal Login
Members
Home
>
Communications
>
Provider Network News
>
STELARA® Biosimilars: Food and Drug Administration (FDA)- Approved Ustekinumab Biosimilars for Prescribin
Section Menu...
Communications
• Provider Newsletters
• TMHP & HHSC Notices
Advanced Search
Claims & Payments
Communications
Provider Network News
Provider Newsletters
TMHP & HHSC Notices
Dates of Service (DOS) Calculator
Medical Policies
Members
Our Network
Our Services
Prior Authorization
Renewal Assistance via Email Disenrolled
Resources
Log Out
STELARA® Biosimilars: Food and Drug Administration (FDA)- Approved Ustekinumab Biosimilars for Prescribin
06/29/2026
Download PDF File
< Back
Loading...